MoFo Perspectives Podcast
MoFo Perspectives Podcast
Morrison & Foerster LLP (MoFo)
We are Morrison & Foerster. We are MoFo. We are synonymous with a commitment to client service and advisors to market-changing deals and impact litigation. Our clients include some of the largest financial institutions, Fortune 100 companies, and leading technology and life sciences companies. We represent investment funds and startup companies, and over the years have supported their growth and development as leading industry players and household brands.
When Your Life Sciences Are on the Line: Securities Litigation
Morrison Foerster partners Kate Driscoll and Nate Mendell, both former federal prosecutors and members of the firm’s Investigations + White Collar Defense Group, hosted the thirteenth episode of When Your Life Sciences Are on the Line, where leading practitioners and thought leaders share the insights and advice needed to manage business and legal risk in the life sciences sector.
May 20
15 min
Above Board: What Boards Need to Know About Prediction Markets
In this episode of the Above Board podcast, hosts Scott Lesmes and Haima Marlier are joined by Morrison Foerster partners Trevor Levine and Ryan Adams to examine the rapid rise of prediction markets and the governance, compliance, and enforcement questions they raise for public companies. Trevor explains how prediction markets operate, why they fall under CFTC jurisdiction, and the regulatory safeguards built into these markets. Ryan then explores the insider trading and anti-fraud risks prediction markets create for public companies, particularly where employees may trade on confidential or non-public information tied to corporate events. The discussion closes with practical guidance for boards and legal teams, including why companies should proactively update insider trading policies, codes of conduct, and employee training to expressly address prediction market activity.
Apr 30
20 min
DCP+ Podcast Episode 5: Georgina Merhom on How Quality Data Can Transform Financial Services, Part 2
In this episode of our Data, Cyber + Privacy PLUS podcast, hosts Kaylee Cox Bankston and Boris Segalis continue their conversation with Georgina Merhom, data scientist and founder of SOLO. They explore the structural gaps in today’s financial data ecosystem, the importance of data traceability, and how evolving ownership models are reshaping the economics of data.
Mar 19
32 min
Above Board: Securities Litigation & Enforcement Outlook for 2026
Scott Lesmes and Haima Marlier are joined by Morrison Foerster Securities Litigation partners Jamie Levitt and Ryan Keats to discuss what public companies can expect in securities litigation and enforcement in 2026.
Mar 11
24 min
Episode 25 – Looking Ahead: What’s Next for Responsible Business in 2026
The 25th episode in this series focuses on “Looking Ahead: What’s Next for Responsible Business in 2026,” featuring Aron Cramer, President and CEO of BSR, in conversation with Suz Mac Cormac, co-chair of the Sustainability + Corporate Responsibility and Social Enterprise + Impact Investing practices at Morrison Foerster.
Jan 29
51 min
When Your Life Sciences Are on the Line: AI and the FDA
Morrison Foerster partners Kate Driscoll and Nate Mendell, both former federal prosecutors and members of the firm’s Investigations + White Collar Defense Group, hosted the twelfth episode of When Your Life Sciences Are on the Line, where leading practitioners and thought leaders share the insights and advice needed to manage business and legal risk in the life sciences sector. In this episode, Kate and Nate speak with Brigid Bondoc, partner and leader of Morrison Foerster’s U.S. Food and Drug Administration (FDA) & Healthcare Regulatory and Compliance Group. Together, they discuss the evolving role of artificial intelligence (AI) within the FDA and its implications for the life sciences industry. They address how the FDA is beginning to integrate AI tools like “Elsa” to improve efficiency in inspections, data analysis, and safety monitoring. Brigid also explores key regulatory and compliance challenges surrounding AI-driven clinical decision support software, emphasizing the importance of explainability and human oversight. The conversation closes with an examination of the FDA’s new approach to releasing complete response letters, and how this increased transparency may reshape industry strategies for engagement with the agency.
Jan 13
25 min
DCP+ Podcast Episode 4: Georgina Merhom on How Quality Data Can Transform Financial Services, Part 1
In this episode, hosts Kaylee Cox Bankston and Boris Segalis discuss their latest favorite uses of AI and the new CCPA developments before sitting down with Georgina Merhom, data scientist and founder of Solo, for the first installment of a two-part conversation exploring the foundations of trustworthy data and AI in financial services.
Dec 15, 2025
34 min
DCP+ Episode 3: AI and the Evolution of National Security Policy
In this episode of our Data, Cyber + Privacy PLUS podcast, hosts Kaylee Cox Bankston and Boris Segalis sit down with Carrie Cordero, General Counsel and Robert M. Gates Senior Fellow at the Center for a New American Security, for a thought-provoking conversation about the emerging AI regulatory landscape, the bipartisan push to strengthen cybersecurity, and the growing influence of private-sector innovators in shaping national security policy.
Nov 24, 2025
31 min
Episode 24 - 2025 Climate Week NYC Debrief
The 24th episode in this series focuses on a “2025 Climate Week NYC Debrief,” featuring Helen Clarkson, CEO of Climate Group, in conversation with Aron Cramer, President and CEO of BSR. Helen and Aron provide their insights on a debriefing of the events of Climate Week NYC 2025. Their discussion also delves into actionable insights and innovative approaches to sustainability, with a particular emphasis on technology-driven climate action, supply chain transformation, sustainable investment, and nature-based solutions.
Sep 30, 2025
51 min
When Your Life Sciences Are on the Line Podcast Ep. 11: FDA Policy
Morrison Foerster partners Kate Driscoll and Nate Mendell, both former federal prosecutors and members of the firm’s Investigations + White Collar Defense Group, hosted the eleventh episode of When Your Life Sciences Are on the Line, where leading practitioners and thought leaders share the insights and advice needed to manage business and legal risk in the life sciences sector.
Sep 17, 2025
26 min
Load more